Published 14 hours ago • loading... • Updated 14 hours ago

Marine Compounds Identified as Potential GLP-1 Receptor Agonists

A multi-stage computational study identified three marine-derived compounds as potential small-molecule GLP-1 receptor agonists with nutraceutical potential for diabetes and obesity management.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

Scienmag: Latest Science and Health News

Reposted by

BIOENGINEER.ORG

Marine Compounds Identified as Potential GLP-1 Receptor Agonists

A multi-stage computational study identified three marine-derived compounds as potential small-molecule GLP-1 receptor agonists with nutraceutical potential for diabetes and obesity management.

14 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated13 hours agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Scienmag: Latest Science and Health News broke the news 14 hours ago on Monday, November 9, 2026.

Sources are mostly out of (0)

Marine Compounds Identified as Potential GLP-1 Receptor Agonists

2 Articles

2 Articles

Marine Compounds Identified as Potential GLP-1 Receptor Agonists

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

UK collaboration tackles diabetes through food-as-medicine programs

Nick Jonas Details What He "Resents" About His Diabetes Over 20 Years After Diagnosis

Similar News Topics

Similar News Topics

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

UK collaboration tackles diabetes through food-as-medicine programs

Nick Jonas Details What He "Resents" About His Diabetes Over 20 Years After Diagnosis

Marine Compounds Identified as Potential GLP-1 Receptor Agonists

2 Articles

2 Articles

Marine Compounds Identified as Potential GLP-1 Receptor Agonists

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

UK collaboration tackles diabetes through food-as-medicine programs

Nick Jonas Details What He "Resents" About His Diabetes Over 20 Years After Diagnosis

Similar News Topics

Similar News Topics

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

UK collaboration tackles diabetes through food-as-medicine programs

Nick Jonas Details What He "Resents" About His Diabetes Over 20 Years After Diagnosis

Bias Distribution

Factuality